Abbott, CAT report D2E7 data

Cambridge Antibody (LSE:CAT; CATG) and partner ABT said that all three doses of D2E7 adalimumab significantly reduced the signs and symptoms of rheumatoid arthritis (RA) in their double-blind, placebo...